Comments
yourfanat wrote: I am using another tool for Oracle developers - dbForge Studio for Oracle. This IDE has lots of usefull features, among them: oracle designer, code competion and formatter, query builder, debugger, profiler, erxport/import, reports and many others. The latest version supports Oracle 12C. More information here.
Cloud Computing
Conference & Expo
November 2-4, 2009 NYC
Register Today and SAVE !..

2008 West
DIAMOND SPONSOR:
Data Direct
SOA, WOA and Cloud Computing: The New Frontier for Data Services
PLATINUM SPONSORS:
Red Hat
The Opening of Virtualization
GOLD SPONSORS:
Appsense
User Environment Management – The Third Layer of the Desktop
Cordys
Cloud Computing for Business Agility
EMC
CMIS: A Multi-Vendor Proposal for a Service-Based Content Management Interoperability Standard
Freedom OSS
Practical SOA” Max Yankelevich
Intel
Architecting an Enterprise Service Router (ESR) – A Cost-Effective Way to Scale SOA Across the Enterprise
Sensedia
Return on Assests: Bringing Visibility to your SOA Strategy
Symantec
Managing Hybrid Endpoint Environments
VMWare
Game-Changing Technology for Enterprise Clouds and Applications
Click For 2008 West
Event Webcasts

2008 West
PLATINUM SPONSORS:
Appcelerator
Get ‘Rich’ Quick: Rapid Prototyping for RIA with ZERO Server Code
Keynote Systems
Designing for and Managing Performance in the New Frontier of Rich Internet Applications
GOLD SPONSORS:
ICEsoft
How Can AJAX Improve Homeland Security?
Isomorphic
Beyond Widgets: What a RIA Platform Should Offer
Oracle
REAs: Rich Enterprise Applications
Click For 2008 Event Webcasts
In many cases, the end of the year gives you time to step back and take stock of the last 12 months. This is when many of us take a hard look at what worked and what did not, complete performance reviews, and formulate plans for the coming year. For me, it is all of those things plus a time when I u...
SYS-CON.TV
TiGenix : to Present at Key Conferences H1 2013
TiGenix to Present at Key Conferences H1 2013

LEUVEN, BELGIUM -- (Marketwire) -- 02/04/13 -- TiGenix (EURONEXT BRUSSELS: TIG), a leader in the field of cell therapy, announced today that during the first half of 2013 the company will present at a number of key events in Europe and the U.S. geared at investor, industry, and academic audiences to highlight the commercial potential of ChondroCelect®, the only approved cell therapy in Europe, and of the company's innovative proprietary allogeneic stem cell platform with programs in Phase II, and III for respectively the treatment of rheumatoid arthritis (Cx611) and perianal fistulas in Crohn's disease (Cx601).

February 11-12
BIO CEO Investor Conference, The Waldorf Astoria, New York, NY, U.S.
Presenter: Eduardo Bravo, CEO
Date & time: Tuesday, February 12, 8:30 - 8:55
Room: Room Conrad
Click here for access to live webcast (registration free, but required)
Replay available 1 hour after live event; archived webcast expires May 12, 2013

February 19
8th Annual Stem Cell Summit, Battery Gardens, Battery Park, New York, NY, U.S.
Presenter: Eduardo Bravo, CEO
Date & time: Tuesday, February 19, 11:55 - 12:18

March 11-13
BIO-Europe Spring, Centre Convencions Internacional, Barcelona, Spain
Attendees: Eduardo Bravo, CEO, Claudia Jiménez, Senior Director Corporate Development

March 16
KBC Bolero/Flanders Bio Retail Event, KBC Tower, Ghent, Belgium
Presenter: Eduardo Bravo, CEO

March 19
KBC Healthcare Conference, Brussels, Belgium
Attendees: Eduardo Bravo, CEO, Claudia D'Augusta, CFO

March 23
Dag van de Belegger, KBC Private Banking, Leuven, Belgium
Presenter: Wilfried Dalemans, CTO
Location: Archipel Business Center
Date & time: Saturday, March 23, 11:45 - 12:30

April 15-16
8th edition European Smallcap Event, Paris, France
Attendees: Eduardo Bravo, CEO, Claudia D'Augusta, CFO

April 17
BioCapital, The Grand, Amsterdam, the Netherlands
Presenter: Claudia D'Augusta, CFO

April 17
RegenMed Investor Day, New York, NY, U.S.
Presenter: Eduardo Bravo, CEO

April 22-25
BIO International Convention, McCormick Place, Chicago, Illinois, U.S.
Attendee: Claudia Jimenez, Senior Director Corporate Development

April 23
6thAnnual Kempen & Co Healthcare Conference, Amsterdam, the Netherlands
Attendee: Claudia D'Augusta, CFO

May 21-23
World Stem Cell & Regenerative Medicine Congress, Victoria Plaza, London, UK.
Presenter: Eduardo Bravo, CEO
Date & time: Tuesday, May 21, 10:05 - 10:30
Title: Commercial financing: exploiting translational funding opportunities

May 22-23
BioEquity Europe 2013, Stockholm, Sweden
Presenter: Eduardo Bravo, CEO

May 30
Knowledge for Growth, ICC Ghent, Belgium
Attendee: Wilfried Dalemans, CTO

About TiGenix

TiGenix NV (EURONEXT BRUSSELS: TIG) is a leading European cell therapy company with a marketed product for cartilage repair, ChondroCelect®, and a strong pipeline with clinical stage allogeneic adult stem cell programs for the treatment of autoimmune and inflammatory diseases. TiGenix is based out of Leuven (Belgium) and has operations in Madrid (Spain), and Sittard-Geleen (the Netherlands). For more information please visit www.tigenix.com.

Forward-looking information
This document may contain forward-looking statements and estimates with respect to the anticipated future performance of TiGenix and the market in which it operates. Certain of these statements, forecasts and estimates can be recognised by the use of words such as, without limitation, "believes", "anticipates", "expects", "intends", "plans", "seeks", "estimates", "may", "will" and "continue" and similar expressions. They include all matters that are not historical facts. Such statements, forecasts and estimates are based on various assumptions and assessments of known and unknown risks, uncertainties and other factors, which were deemed reasonable when made but may or may not prove to be correct. Actual events are difficult to predict and may depend upon factors that are beyond TiGenix' control. Therefore, actual results, the financial condition, performance or achievements of TiGenix, or industry results, may turn out to be materially different from any future results, performance or achievements expressed or implied by such statements, forecasts and estimates. Given these uncertainties, no representations are made as to the accuracy or fairness of such forward-looking statements, forecasts and estimates. Furthermore, forward-looking statements, forecasts and estimates only speak as of the date of the publication of this document. TiGenix disclaims any obligation to update any such forward-looking statement, forecast or estimates to reflect any change in TiGenix' expectations with regard thereto, or any change in events, conditions or circumstances on which any such statement, forecast or estimate is based, except to the extent required by Belgian law.

For more information:
Eduardo Bravo
Chief Executive Officer
eduardo.bravo@tigenix.com

Claudia D'Augusta
Chief Financial Officer
claudia.daugusta@tigenix.com

Hans Herklots
hans.herklots@tigenix.com
+32 16 39 60 97

About Marketwired .
Copyright © 2009 Marketwired. All rights reserved. All the news releases provided by Marketwired are copyrighted. Any forms of copying other than an individual user's personal reference without express written permission is prohibited. Further distribution of these materials is strictly forbidden, including but not limited to, posting, emailing, faxing, archiving in a public database, redistributing via a computer network or in a printed form.

SOA World Latest Stories
As more applications and services move "to the cloud" (public or on-premise) cloud environments are increasingly adopting and building out traditional enterprise features. This in turn is enabling and encouraging cloud adoption from enterprise users. In many ways the definition is blur...
Internet of @ThingsExpo Silicon Valley announced on Friday its first 18 all-star speakers and sessions for its upcoming event, which will take place November 4-6, 2014, at the Santa Clara Convention Center in California. @ThingsExpo, the first and largest IoT event in the world, debute...
Until recently, many organizations required specialized departments to perform mapping and geospatial analysis, and they used Esri on-premise solutions for that work. In his session at 15th Cloud Expo, Dave Peters, author of the Esri Press book Building a GIS, System Architecture Des...
Back when we were doing DB2 at IBM, there was an important older product called IMS which brought significant revenue. With another database product coming (based on relational technology), IBM did not want any cannibalization of the existing revenue stream. Hence we coined the phrase ...
Nick O'Leary is an Emerging Technology Specialist at IBM where he gets to do interesting things with interesting technologies and also play with toys. With a background in pervasive messaging, he is a developer on the Eclipse Paho project and sits on the OASIS MQTT Technical Committee....
Bsquare is a global leader of embedded software solutions. We enable smart connected systems at the device level and beyond that millions use every day and provide actionable data solutions for the growing Internet of Things (IoT) market. We empower our world-class customers with our...
Subscribe to the World's Most Powerful Newsletters
Subscribe to Our Rss Feeds & Get Your SYS-CON News Live!
Click to Add our RSS Feeds to the Service of Your Choice:
Google Reader or Homepage Add to My Yahoo! Subscribe with Bloglines Subscribe in NewsGator Online
myFeedster Add to My AOL Subscribe in Rojo Add 'Hugg' to Newsburst from CNET News.com Kinja Digest View Additional SYS-CON Feeds
Publish Your Article! Please send it to editorial(at)sys-con.com!

Advertise on this site! Contact advertising(at)sys-con.com! 201 802-3021


SYS-CON Featured Whitepapers
ADS BY GOOGLE